Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

ImmunityBio (IBRX) Other Gross PP&E Adjustments: 2014-2025

Historic Other Gross PP&E Adjustments for ImmunityBio (IBRX) over the last 10 years, with Sep 2025 value amounting to $205.1 million.

  • ImmunityBio's Other Gross PP&E Adjustments rose 2.57% to $205.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $795.7 million, marking a year-over-year increase of 3.89%. This contributed to the annual value of $182.5 million for FY2024, which is 6.51% up from last year.
  • Per ImmunityBio's latest filing, its Other Gross PP&E Adjustments stood at $205.1 million for Q3 2025, which was up 0.98% from $203.1 million recorded in Q2 2025.
  • Over the past 5 years, ImmunityBio's Other Gross PP&E Adjustments peaked at $205.1 million during Q3 2025, and registered a low of $76.5 million during Q4 2021.
  • Its 3-year average for Other Gross PP&E Adjustments is $192.3 million, with a median of $195.2 million in 2024.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first dropped by 7.77% in 2021, then surged by 91.06% in 2022.
  • ImmunityBio's Other Gross PP&E Adjustments (Quarterly) stood at $76.5 million in 2021, then spiked by 91.06% to $146.2 million in 2022, then grew by 17.21% to $171.4 million in 2023, then grew by 6.51% to $182.5 million in 2024, then climbed by 2.57% to $205.1 million in 2025.
  • Its Other Gross PP&E Adjustments was $205.1 million in Q3 2025, compared to $203.1 million in Q2 2025 and $204.9 million in Q1 2025.